Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. (Q44509729)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. |
scientific article |
Statements
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies (English)
Cheryl A London
Alison L Hannah
Regina Zadovoskaya
May B Chien
Cynthia Kollias-Baker
Mona Rosenberg
Sue Downing
Gerald Post
Joseph Boucher
Narmada Shenoy
Dirk B Mendel
Gerald McMahon
Julie M Cherrington
Identifiers
Sitelinks
Wikipedia(0 entries)
Wikibooks(0 entries)
Wikinews(0 entries)
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Multilingual sites(0 entries)
